Average Co-Inventor Count = 14.04
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (18 from 2,405 patents)
2. Merck Canada Inc. (5 from 40 patents)
18 patents:
1. 11230547 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
2. 10544147 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
3. 9938281 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
4. 9730940 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
5. 9682978 - 2,6,7 substituted purines as HDM2 inhibitors
6. 9586931 - Triazolyl derivatives as Syk inhibitors
7. 9540377 - 2,6,7,8 substituted purines as HDM2 inhibitors
8. 9487504 - Imidazolyl analogs as syk inhibitors
9. 9416111 - Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors
10. 9376418 - Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
11. 9353066 - Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors
12. 9328099 - Cyanomethylpyrazole carboxamides as janus kinase inhibitors
13. 9242984 - Pyrazolyl derivatives as Syk inhibitors
14. 8993756 - Pyrrolopyrimidines as janus kinase inhibitors
15. 8962611 - Substituted imidazopyridines as HDM2 inhibitors